CLVT

$2.54

Post-MarketAs of Mar 17, 8:00 PM UTC

Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

AAPLMSFTGOOGL

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$2.54
Potential Upside
5%
Whystock Fair Value$2.67
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorTechnology
IndustryInformation Technology Services

Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers s...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.63B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.51
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-4.03%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.73

Recent News

Simply Wall St.
Mar 14, 2026

Is Clarivate (CLVT) Pricing Reflect A Real Shift After Recent 30 Day Surge

If you are looking at Clarivate and wondering whether the current share price reflects its true worth, you are not alone. This article is built to help you weigh what the numbers might be telling you. The stock last closed at US$2.57, with a 42.0% gain over the past 30 days, set against a 6.2% decline over 7 days and longer term returns of 20.7% lower year to date and 37.8% lower over the past year. These swings sit on top of a much tougher multi year run, with the share price 73.7% lower...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Mar 12, 2026

Is Clarivate Plc (CLVT) One of the Best Penny Stocks to Buy According to Reddit?

Clarivate Plc (NYSE:CLVT) is one of the best penny stocks to buy according to Reddit. Citi cut the price target on Clarivate Plc (NYSE:CLVT) to $2.80 from $4.25 on March 4, maintaining a Neutral rating on the shares. In another development, RBC Capital also cut the price target on the stock to $3 from $5 […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Motley Fool
Mar 11, 2026

EXL Stock Down 41% Year Over Year as One Investor Reveals $68 Million Exit

EXLS delivers digital operations and analytics solutions to insurance, healthcare, and life sciences clients worldwide.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
24/7 Wall St.
Mar 11, 2026

Clarivate: The Data Intelligence Company Flying Under the Radar

Most investors have never heard of Clarivate. The company operates largely outside mainstream investor attention. While the market fixates on AI darlings trading at triple-digit multiples, this London-based data intelligence company sits at $2.64 per share with a $1.67 billion market cap, quietly generating hundreds of millions in free cash flow and embedding itself deeper ... Clarivate: The Data Intelligence Company Flying Under the Radar

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 4, 2026

Clarivate (CLVT) Is Up 5.1% After Narrowing Impairments But Guiding For 2026 Net Losses

In February 2026, Clarivate Plc reported fourth-quarter 2025 revenue of US$617 million and full-year revenue of US$2.46 billion, with quarterly net income turning positive at US$3.1 million while the full year remained in a net loss of US$201.1 million. The company also sharply reduced goodwill and intangible asset impairments to US$15.0 million and issued 2026 guidance that anticipates continued net losses, highlighting the earnings impact of portfolio disposals and ongoing business...

BEARISH
Negative press. News cycle fixated on risk factors or misses.